NGS - Next Generation Sequencing

We offer NGS sequencing (next generation sequencing) in nanopore technology developed by Oxford Nanopore Technologies. This unique technology allows you to analyze nucleic acids without having to introduce an amplification step during library creation.
ikona - wyspa - tło dla genXonegrafika badania DNA w genXone - analizy genetyczne

About genXone

We specialize in NGS (next generation sequencing) and medical diagnostics. We are the first in Poland and one of the first ten in the world laboratories using nanopore sequencing technology in many areas of science, business and medicine.

grafika tło - wysepka dla genXoneilustracja dla sekwencjonowania nanoporowego genXone

Nanopre sequencing

We offer NGS sequencing (next generation sequencing) in nanopore technology developed by Oxford Nanopore Technologies. This unique technology allows you to analyze nucleic acids without having to introduce an amplification step during library creation.

Bespoke analysis

Read more

Bioinformatic Analysis

Read more

Metagenomic sequencing

Read more

16S and/or ITS Gene Sequencing

Read more

Whole Genome Sequencing

Read more

SARS-CoV-2 genome sequencing

Read more
tło grafiki dla genXoneIlustracja dla badań diagnostycznych

Diagnostics

After a detailed medical interview, diagnostic molecular tests are the fastest and best tool in diagnosing most diseases and assessing the patient's health condition.

Urogenital Infections - Real Time PCR Tests

Read more

Respiratory Infection - Real Time PCR Tests

Read more

Nervous System Infection - Real Time PCR test

Read more

Gastrointestinal Infections - Real Time PCR Tests

Read more

News feed

23 September 2022 

genXone & gMendel join forces in diagnostics of genetic disorders

Biotech company genXone has signed a letter of intent to significantly expand its cooperation with Danish gMendel®. The joint efforts of two companies began earlier this year, with trial project for the diagnosis of genetic disorders. The current phase begins with negotiations on an investment agreement and the expected result is the innovative tool for […]

7 September 2022 

Polish-Danish Life Science Business Seminar

On the 6th of September 2022, at the Foreign Trade Office of the Polish Investment and Trade Agency HQ in Copenhagen, R&D Director Prof. Lukasz Krych spoke about our company and the cooperation that genXone has with various institutions based in Denmark. The main purpose of the seminar was to initiate a debate on the […]

27 May 2022 

News

Yesterday (26 May 2022), Vice President Jolanta Kołodziejczyk participated in CEBioForum 2022. It was a great pleasure to receive the Anti-Covid Solution Award. Thank you very much! Congratulaions to the organizers of a very successful event! Today we participate in the conference “Prehabilitacja 2022 – to działa“. It is a fantastic experience to listen to […]

16 May 2022 

XI Scientific and Training Conference “Public Health Threats”

It is a great pleasure to invite you to follow the XI Scientific and Training Conference “Public Health Threats”, which will be held in Pisz, on 23-25 May 2022. The conference will summarize activities from the pandemic period in Poland. On the first day in the panel: Substantive Session Part 1 “COVID-19 … and what […]

13 May 2022 

More than 37 percent revenue growth for genXone in first quarter of 2022

Press Release Biotechnology company genXone has achieved in the first quarter of this year an impressive, over 37 percent increase in revenue. From January to the end of March this year it was over PLN 7.3 million, while a year earlier it was about PLN 5.3 million. Net profit in the first quarter of this […]

4 May 2022 

“Smart Specialization for Wielkopolska” award ceremony

Representatives of genXone received an award in the XIV edition of the Competition for the Marshal of the Wielkopolska Region Award “i-Wielkopolska – Innovative for Wielkopolska”. The ceremony of honoring the winners of the 2021 edition of the Competition took place on April 25, 2022, during the session of the Assembly of the Wielkopolska Region. […]

25 March 2022 

News

Yesterday, the Extraordinary General Meeting of Shareholders was held, during which several resolutions important for the company’s development were adopted. Resignation from the function of Vice President of genXone S.A. was submitted by Jakub Swadźba. Thank you for your contribution to the development of the company. Mr. Jakub Swadźba and Mr. Dariusz Zowczak were appointed […]

11 February 2022 

The company summed up a successful 2021

genXone has recorded a net profit of over PLN 8.7 million in 2021. This is over PLN 1.6 million more than in 2020 thnaks to the focus on operating activities and consistent implementation of projects included in the development strategy. genXone had been developing sales of its own products and services based on nanopore sequencing, […]